跳至主要内容
临床试验/IRCT201103171414N23
IRCT201103171414N23已完成2 期

Investigation on autologous mesenchymal stem cell transplantation in diabetic neurophaty

???Endocrinology & Metabolism Research Institute Tehran University Of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • 1-People with diabetes type one that their disease passed at least 10 years 2-signing informed consent, 3-age 40-60 years4- All patients are eligible for cell therapy (under protocol) 5 - HbA1c = 7.5% (blood glucose is controlled at least of one month) 6 - BP = 130/80Exclusion criteria: 1 - acute inflammation of vascular 2 - acute thrombosis (three months) 3 - recent bleeding in the retina (the last three months) 4 - pulmonary hypertension 5 - liver disease 6- tumors in bone marrow or any malignancy is diagnosed 7 - infectious diseases 8-mental illness 9- generalized edema 10 - malignancy 11 - pregnancy 12 - to use any walking aids 13 - having a foot ulcer during the study 14 - amputation of limbs

排除标准

  • 未提供

研究者

发起方
???Endocrinology & Metabolism Research Institute Tehran University Of Medical Sciences

相似试验

Effect of mesenchymal stem cells transplantation to... | 临床试验